A comparison of sibutramine and dexfenfluramine in the treatment of obesity

Obesity Research

Volumn 6, Issue 4, 1998, Pages 285-291

  Thomas, Florence ^a  

^a Laboratoires Knoll France   (France)

Author keywords

Appetite suppressant; Noradrenaline; Serotonin; Weight loss

Indexed keywords

ANOREXIGENIC AGENT; CYCLOBUTANE DERIVATIVE; DEXFENFLURAMINE; SEROTONIN AGONIST; SIBUTRAMINE;

ADULT; ARTICLE; BODY CONSTITUTION; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; FEMALE; HUMAN; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; APPETITE DEPRESSANTS; BODY CONSTITUTION; BODY MASS INDEX; BODY WEIGHT; CYCLOBUTANES; DEXFENFLURAMINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; SEROTONIN AGONISTS; TREATMENT OUTCOME;

EID: 0032111931     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1550-8528.1998.tb00351.x     Document Type: Article

References (12)

1. Golstein DJ, Potvin JH. Long-term weight loss: the effect of pharmacologie agents. Am J Clin Nutr. 1994;60:647-57.
2. Blundell JE, Hill AJ. Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans. Int J Obes. 1987;11:141-55.
3. Bray GA. Drug treatment of obesity. Am J Clin Nutr. 1992; 55:538S-44S.
4. Davis R, Faulds D. Dexfenfluramine. An updated review of its therapeutic use in the management of obesity. Drugs. 1996; 52:696-724.
5. Gundlah C, Martin KF, Heal DJ, Auerbach SB. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. J Pharmacol Exp Ther. 1997;283:581-91.
6. Buckett WR, Thomas PC, Luscombe GP. The pharmacology of sibutramine hydrochloride (BTS 54524), a new antidepressant which induces rapid noradrenergic downregulation. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12:575-84.
7. Luscombe GP, Slater NA, Lyons MB, Wynne RD, Scheinbaum ML, Buckett WR. Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HC1. Psychopharmacology. 1990;100:345-9.
8. Aspley S, Broughton DM, Prow MR, Martin KF, Heal DJ. Sibutramine and its active metabolites do not release [3H]-noradrenaline from rat heart or brain slices in vitro: comparison with other weight reducing and sympathomimetic drugs. Br J Pharmacol. 1997;120:353P.
9. Heal DJ, Prow MR, Hearson M, Buckett WR. Efflux of [3H]-dopamine from superfused rat striatal slices: predictive value for detecting stimulant drugs of abuse. Br J Pharmacol 1996;117:325P.
10. 3 and atypical β-adrenoceptors. Med Res Rev. 1993;13:663-729.
11. Guarattini S, Samanin R. Anorectic drugs and brain neurotransmitters. In: Silverstone T, ed. Appetite and Food Intake. Berlin: Dahlem Konferenze; 1976:83-108.
12. Silverstone T. Appetite suppressants: a review. Drugs. 1982; 43:820-36.